PEGylated estradiol benzoate liposomes as a potential local vascular delivery system for treatment of restenosis

References

• Acharya G, Park K. Mechanisms of controlled drug release from drug-eluting stents. Adv Drug Deliv Rev 2006; 58: 387–401
   PubMed Web of Science ®Google Scholar
• Allen TM, Hansen C. Pharmacokinetics of stealth versus conventional liposomes: Effect of dose. Biochim Biophys Acta 1991; 1068: 133–41
   PubMed Web of Science ®Google Scholar
• Armstrong NA. Pharmaceutical experimental design and interpretation. Taylor & Francis Group, New York 2006
   Google Scholar
• Banai S, Chorny M, Gertz SD, Fishbein I, Gao J, Perez L, Lazarovichi G, Gazit A, Levitzki A, Golomb G. Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries. Biomaterials 2005; 26: 451–61
   PubMed Web of Science ®Google Scholar
• Betageri GV, Parsons DL. Drug encapsulation and release from multilamellar and unilamellar liposomes. Int J Pharm 1992; 81: 235–41
   Web of Science ®Google Scholar
• Brito L, Amiji M. Nanoparticulate carriers for the treatment of coronary restenosis. Int J Nanomedicine 2007; 2: 143–61
   PubMed Web of Science ®Google Scholar
• Burt HM, Hunter WL. Drug-eluting stents: An innovative multidisciplinary drug delivery platform. Adv Drug Deliv Rev 2006; 58: 345–6
   PubMedGoogle Scholar
• Costa MA, Simon DI. Molecular basis of restenosis and drug-eluting stents. Circulation 2005; 111: 2257–73
   PubMed Web of Science ®Google Scholar
• Dos Santos N, Allen C, Doppen AM, Anantha M, Cox KA, Gallagher RC, Karlsson G, Edwards K, Kenner G, Samuels L, et al. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: Relating plasma circulation lifetimes to protein binding. Biochim Biophys Acta 2007; 1768: 1367–77
   PubMed Web of Science ®Google Scholar
• Dos Santos N, Mayer LD, Abraham SA, Gallagher RC, Cox KA, Tardi PG, Bally MB. Improved retention of idarubicin after intravenous injection obtained for cholesterol-free liposomes. Biochim Biophys Acta 2002; 1561: 188–201
   PubMed Web of Science ®Google Scholar
• Drummond DC, Meyer O, Hong K, Kirpotin DB, Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 1999; 51: 691–743
   PubMed Web of Science ®Google Scholar
• Drummond DC, Noble CO, Hayes ME, Park JW, Kirpotin DB. Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development. J Pharm Sci 2008; 97: 4696–740
   PubMed Web of Science ®Google Scholar
• Foegh ML, Asotra S, Howell MH, Ramwell PW. Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. J Vasc Surg 1994; 19: 722–6
   PubMedGoogle Scholar
• Genereux P, Mehran R. Are drug-eluting stents safe in the long term?. CMAJ 2009; 180: 154–5
   PubMedGoogle Scholar
• Hanke H, Hassenstein S, Ulmer A, Kamenz J, Oberhoff M, Haase KK, Baumbach A, Gown AM, Karsch KR. Accumulation of macrophages in the arterial vessel wall following experimental balloon angioplasty. Eur Heart J 1994; 15: 691–8
   PubMedGoogle Scholar
• Herrington D. Role of estrogens, selective estrogen receptor modulators and phytoestrogens in cardiovascular protection. Can J Cardiol 2000; 16 Suppl E: 5E–9E
   Google Scholar
• Immordino ML, Brusa P, Arpicco S, Stella B, Dosio F, Cattel L. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel. J Control Release 2003; 91: 417–29
   PubMed Web of Science ®Google Scholar
• Immordino ML, Dosio F, Cattel L. Stealth liposomes: Review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine 2006; 1: 297–315
   PubMed Web of Science ®Google Scholar
• Kedia G, Lee MS. Stent thrombosis with drug-eluting stents: A re-examination of the evidence. Catheter Cardiovasc Interv 2007; 69: 782–9
   PubMedGoogle Scholar
• Kirby C, Clarke J, Gregoriadis G. Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem J 1980; 186: 591–8
   PubMed Web of Science ®Google Scholar
• Komatsu R, Ueda M, Naruko T, Kojima A, Becker AE. Neointimal tissue response at sites of coronary stenting in humans: Macroscopic, histological, and immunohistochemical analyses. Circulation 1998; 98: 224–33
   PubMed Web of Science ®Google Scholar
• Labhasetwar V, Song C, Humphrey W, Shebuski R, Levy R. Arterial uptake of biodegradable nanoparticles: Effect of surface modifications. J Pharm Sci 1998; 87: 1229–34
   PubMed Web of Science ®Google Scholar
• Lantin-Hermoso RL, Rosenfeld CR, Yuhanna IS, German Z, Chen Z, Shaul PW. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am J Physiol 1997; 273: L119–26
   Web of Science ®Google Scholar
• Lee MS, David EM, Makkar RR, Wilentz JR. Molecular and cellular basis of restenosis after percutaneous coronary intervention: The intertwining roles of platelets, leukocytes, and the coagulation-fibrinolysis system. J Pathol 2004; 203: 861–70
   PubMed Web of Science ®Google Scholar
• Luscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, Virmani R. Drug-eluting stent and coronary thrombosis: Biological mechanisms and clinical implications. Circulation 2007; 115: 1051–8
   PubMed Web of Science ®Google Scholar
• McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519–21
   PubMed Web of Science ®Google Scholar
• Melikian N, Airoldi F, Di Mario C. Coronary bifurcation stenting. Current techniques, outcome and possible future developments. Minerva Cardioangiol 2004; 52: 365–78
   PubMedGoogle Scholar
• Melikian N, Wijns W. Drug-eluting stents: A critique. Heart 2008; 94: 145–52
   PubMedGoogle Scholar
• Moreno PR, Bernardi VH, Lopez-Cuellar J, Newell JB, McMellon C, Gold HK, Palacios IF, Fuster V, Fallon JT. Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation 1996; 94: 3098–102
   PubMed Web of Science ®Google Scholar
• Moribe K, Maruyama K, Iwatsuru M. Encapsulation characteristics of nystatin in liposomes: Effects of cholesterol and polyethylene glycol derivatives. Int J Pharm 1999; 188: 193–202
   PubMed Web of Science ®Google Scholar
• Nallamothu R, Wood GC, Kiani MF, Moore BM, Horton FP, Thoma LA. A targeted liposome delivery system for combretastatin A4: Formulation optimization through drug loading and in vitro release studies. PDA J Pharm Sci Technol 2006; 60: 144–55
   PubMedGoogle Scholar
• New G, Moses JW, Roubin GS, Leon MB, Colombo A, Iyer SS, Tio FO, Mehran R, Kipshidze N. Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model. Catheter Cardiovasc Interv 2002; 57: 266–71
   PubMed Web of Science ®Google Scholar
• Ogihara-Umeda I, Kojima S. Cholesterol enhances the delivery of liposome-encapsulated gallium-67 to tumors. Eur J Nucl Med 1989; 15: 612–17
   PubMedGoogle Scholar
• Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005; 45: 2088–92
   PubMed Web of Science ®Google Scholar
• Oparil S, Chen SJ, Chen YF, Durand JN, Allen L, Thompson JA. Estrogen attenuates the adventitial contribution to neointima formation in injured rat carotid arteries. Cardiovasc Res 1999; 44: 608–14
   PubMed Web of Science ®Google Scholar
• Popma JJ, Califf RM, Topol EJ. Clinical trials of restenosis after coronary angioplasty. Circulation 1991; 84: 1426–36
   PubMed Web of Science ®Google Scholar
• Ramana LN, Sethuraman S, Ranga U, Krishnan UM. Development of a liposomal nanodelivery system for nevirapine. J Biomed Sci 2010; 17: 57
   PubMed Web of Science ®Google Scholar
• Ritger PL, Peppas NA. A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release 1987; 5: 23–36
   Google Scholar
• Salam AM, Al Suwaidi J, Holmes DR, Jr. Drug-eluting coronary stents. Curr Probl Cardiol 2006; 31: 8–119
   PubMedGoogle Scholar
• Scheller B, Speck U, Abramjuk C, Bernhardt U, Bohm M, Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 2004; 110: 810–14
   PubMed Web of Science ®Google Scholar
• Semple SC, Chonn A, Cullis PR. Influence of cholesterol on the association of plasma proteins with liposomes. Biochemistry 1996; 35: 2521–5
   PubMed Web of Science ®Google Scholar
• Silbiger S, Lei J, Ziyadeh FN, Neugarten J. Estradiol reverses TGF-beta1-stimulated type IV collagen gene transcription in murine mesangial cells. Am J Physiol 1998; 274: F1113–18
   Google Scholar
• Steffel J, Tanner FC. Biological effects of drug-eluting stents in the coronary circulation. Herz 2007; 32: 268–73
   PubMedGoogle Scholar
• Sukhija R, Mehta JL, Sachdeva R. Present status of coronary bifurcation stenting. Clin Cardiol 2008; 31: 63–6
   PubMedGoogle Scholar
• Sullivan TR, Jr, Karas RH, Aronovitz M, Faller GT, Ziar JP, Smith JJ, O’Donnell TF, Jr, Mendelsohn ME. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest 1995; 96: 2482–8
   PubMed Web of Science ®Google Scholar
• Tsotas VA, Mourtas S, Antimisiaris SG. Dexamethasone incorporating liposomes: Effect of lipid composition on drug trapping efficiency and vesicle stability. Drug Deliv 2007; 14: 441–5
   PubMed Web of Science ®Google Scholar
• Tulis DA. Rat carotid artery balloon injury model. Methods Mol Med 2007; 139: 1–30
   PubMedGoogle Scholar
• Vali AM, Toliyat T, Shafaghi B, Dadashzadeh S. Preparation, optimization, and characterization of topotecan loaded PEGylated liposomes using factorial design. Drug Dev Ind Pharm 2008; 34: 10–23
   PubMed Web of Science ®Google Scholar
• White CR, Shelton J, Chen SJ, Darley-Usmar V, Allen L, Nabors C, Sanders PW, Chen YF, Oparil S. Estrogen restores endothelial cell function in an experimental model of vascular injury. Circulation 1997; 96: 1624–30
   PubMedGoogle Scholar
• Woodle MC, Lasic DD. Sterically stabilized liposomes. Biochim Biophys Acta 1992; 1113: 171–99
   PubMed Web of Science ®Google Scholar
• Xiong Y, Guo D, Wang L, Zheng X, Zhang Y, Chen J. Development of nobiliside A loaded liposomal formulation using response surface methodology. Int J Pharm 2009; 371: 197–203
   PubMed Web of Science ®Google Scholar
• Zhang JA, Anyarambhatla G, Ma L, Ugwu S, Xuan T, Sardone T, Ahmad I. Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation. Eur J Pharm Biopharm 2005; 59: 177–87
   PubMed Web of Science ®Google Scholar
• Zuidam JZ, de Vrueh R, Crommelin DJA. Characterization of liposomes. Liposomes: A practical approach, VP Torchilin, V Weissig. Oxford University Press, New York 2003; 31–78
   Google Scholar